These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27999021)

  • 1. Development of operationalized intravenous to oral antibiotic switch criteria.
    Akhloufi H; Hulscher M; Melles DC; Prins JM; van der Sijs H; Verbon A
    J Antimicrob Chemother; 2017 Feb; 72(2):543-546. PubMed ID: 27999021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study.
    Rodriguez-Pardo D; Pigrau C; Campany D; Diaz-Brito V; Morata L; de Diego IC; Sorlí L; Iftimie S; Pérez-Vidal R; García-Pardo G; Larrainzar-Coghen T; Almirante B
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1269-76. PubMed ID: 27180242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors' accounts of what influences their clinical practice.
    Broom J; Broom A; Adams K; Plage S
    J Antimicrob Chemother; 2016 Aug; 71(8):2295-9. PubMed ID: 27121400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S; Smith S; Newman D; Ritter W; Burke J; Ramirez JA
    Pharmacotherapy; 1997; 17(3):569-75. PubMed ID: 9165561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
    Trials; 2015 Oct; 16():450. PubMed ID: 26452342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic treatment of appendicular peritonitis in children: is the oral route done?].
    Berthe-Aucejo A; Postaire M; Cheikhlard A; Zahar JR; Bourget P
    Arch Pediatr; 2012 Dec; 19(12):1303-7. PubMed ID: 23107091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. IV. Biological activity of variously substituted 2,3-diaryl-1,3-thiazolidin-4-ones.
    Piscopo E; Diurno MV; Gagliardi R; Mazzoni O; Veneruso G
    Boll Soc Ital Biol Sper; 1989 Sep; 65(9):853-9. PubMed ID: 2627344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.
    McMullan BJ; Andresen D; Blyth CC; Avent ML; Bowen AC; Britton PN; Clark JE; Cooper CM; Curtis N; Goeman E; Hazelton B; Haeusler GM; Khatami A; Newcombe JP; Osowicki J; Palasanthiran P; Starr M; Lai T; Nourse C; Francis JR; Isaacs D; Bryant PA;
    Lancet Infect Dis; 2016 Aug; 16(8):e139-52. PubMed ID: 27321363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
    Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
    Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality indicators to measure appropriate antibiotic use in hospitalized adults.
    van den Bosch CM; Geerlings SE; Natsch S; Prins JM; Hulscher ME
    Clin Infect Dis; 2015 Jan; 60(2):281-91. PubMed ID: 25266285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic intravenous-to-oral switch guidelines: barriers to adherence and possible solutions.
    Warburton J; Hodson K; James D
    Int J Pharm Pract; 2014 Oct; 22(5):345-53. PubMed ID: 24467463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: A practical intervention resulting in reduced length of hospital stay.
    Mouwen AMA; Dijkstra JA; Jong E; Buijtels PCAM; Pasker-de Jong PCM; Nagtegaal JE
    Int J Antimicrob Agents; 2020 Jan; 55(1):105769. PubMed ID: 31362046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of hydrazono derivatives of biological interest.
    Piscopo E; Diurno MV; Gagliardi R; Mazzoni O; de Francesco FM; Parrilli C
    Boll Soc Ital Biol Sper; 1989 Apr; 65(4):311-6. PubMed ID: 2775537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on heterocyclic compounds: spiro [indole-3,2'-thiazolidine] derivatives. Antimicrobial activity of monohalogenated 3'-phenylspiro 3H-indole-3,2'-thiazolidine-2,4' (1H)-diones.
    Piscopo E; Diurno MV; Mazzoni O; Ciaccio AM
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1181-6. PubMed ID: 2100530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing criteria-based early switch/early discharge programmes: a European perspective.
    Nathwani D; Lawson W; Dryden M; Stephens J; Corman S; Solem C; Li J; Charbonneau C; Baillon-Plot N; Haider S; Eckmann C
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S47-55. PubMed ID: 26198369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of unnecessary i.v. antibiotic days using general criteria for antibiotic switch.
    Waagsbø B; Sundøy A; Paulsen EQ
    Scand J Infect Dis; 2008; 40(6-7):468-73. PubMed ID: 18584533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of early intravenous to oral antibiotic switch therapy in the management of prosthetic hip infection treated with one- or two-stage replacement.
    Darley ES; Bannister GC; Blom AW; Macgowan AP; Jacobson SK; Alfouzan W
    J Antimicrob Chemother; 2011 Oct; 66(10):2405-8. PubMed ID: 21742678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.